Limitation of combination therapy of peginterferon and ribavirin for older patients with chronic hepatitis C

被引：0
|
作者：
Iwasaki, Yoshiaki
Araki, Yasuyuki
Takaguchi, Kouichi
Taniguchi, Hideaki
Okamoto, Ryoichi
Kawaguchi, Mitsuhiko
Terada, Ryo
Osawa, Toshiya
Fujioka, Shin-Ichi
Nagano, Takuya
Kita, Keiji
Yamamoto, Kazuhide
Takaki, Akinobu
Kobashi, Haruhiko
Sakaguchi, Kohsaku
Shiratori, Yasushi
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A794 / A795
页数：2
相关论文
共 50 条
  • [1] Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C
    Iwasaki, Y
    Ikeda, H
    Araki, Y
    Osawa, T
    Kita, K
    Ando, M
    Shimoe, T
    Takaguchi, K
    Hashimoto, N
    Kobatake, T
    Tomita, M
    Kawaguchi, M
    Kobashi, H
    Sakaguchi, K
    Shiratori, Y
    [J]. HEPATOLOGY, 2006, 43 (01) : 54 - 63
  • [2] Eruptions in Patients with chronic hepatitis C receiving combination therapy with Telaprevir, Peginterferon and Ribavirin
    Eleftheriadis, V
    Stadler, R.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (11): : 869 - 869
  • [3] Efficacy in patients with dose reduction in combination therapy of peginterferon and ribavirin for chronic hepatitis c
    Arase, Yasuji
    Suzuki, Fumitaka
    Sezaki, Hitomi
    Kawamura, Yusuke
    Suzuki, Yoshiyuki
    Kobayashi, Masahiro
    Akuta, Norio
    Hosaka, Tetsuya
    Yatsuji, Hiromi
    Hirakawa, Miharu
    Kobayashi, Mariko
    Ikeda, Kenji
    Kumada, Hiromitsu
    [J]. INTERVIROLOGY, 2008, 51 (01) : 1 - 6
  • [4] Predictors of thyroid dysfunction in patients with chronic hepatitis C during peginterferon and ribavirin combination therapy
    Jang, E. S.
    Kim, W.
    Park, D-J
    Kim, B-H
    Jung, Y-J
    Kim, D-H
    Kim, Y. J.
    Yoon, J-H
    Lee, H-S
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A40 - A40
  • [5] Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C
    Arase, Yasuji
    Suzuki, Fumitaka
    Suzuki, Yoshiyuki
    Akuta, Norio
    Kawamura, Yusuke
    Kobayashi, Masahiro
    Hosaka, Tetsuya
    Sezaki, Hitomi
    Yatsuji, Hiromi
    Kobayashi, Mariko
    Ikeda, Kenji
    Kumada, Hiromitsu
    [J]. INTERNAL MEDICINE, 2007, 46 (22) : 1827 - 1832
  • [6] Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
    Jung, Young Kul
    Kim, Ju Hyun
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2013, 19 (01) : 26 - 28
  • [7] Peginterferon alfa-2b and ribavirin combination therapy for chronic hepatitis C
    Yeh, Frank
    Gordon, Fredric D.
    [J]. FUTURE VIROLOGY, 2007, 2 (06) : 553 - 563
  • [8] EFFICACY OF COMBINATION THERAPY PEGINTERFERON ALFA-2B AND RIBAVIRIN ON PREVENTION OF HEPATOCELLULAR CARCINOMA IN OLDER PATIENTS WITH CHRONIC HEPATITIS C
    Honda, Takashi
    Katano, Yoshiaki
    Kuzuya, Teiji
    Tachi, Yoshihiko
    Hayashi, Kazuhiko
    Ishigami, Masatoshi
    Nakano, Isao
    Goto, Hidemi
    [J]. HEPATOLOGY, 2011, 54 : 840A - 840A
  • [9] Peginterferon and ribavirin for chronic hepatitis C
    Hoofnagle, Jay H.
    Seeff, Leonard B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23): : 2444 - 2451
  • [10] Noninterventional Trial of Peginterferon α-2a in Combination with Ribavirin in Patients with Chronic Hepatitis C
    Bauer B.
    Dertinger S.
    Hubmann R.
    Pleiner-Duxneuner J.
    [J]. Journal für Gastroenterologische und Hepatologische Erkrankungen, 2019, 17 (3) : 68 - 74
12345